Mount Sinai Establishes Department of Public Health

Rosalind J. Wright, MD, MPH, appointed inaugural Dean for Public Health and Chair of the new Department of Public Health to spearhead a state-of-the-art curriculum in public health research, education, and practice that will systematically integrate with medicine, population health, global health, neurosciences, environmental medicine, data science and Artificial Intelligence (AI) disciplines.

Intravascular Imaging Significantly Improves Survival, Safety, and Outcomes in Cardiovascular Stenting Procedures Over Conventional Angiography

Results from this large-scale synthesis of all prior clinical trials could increase usage of several types of high-resolution imaging for guiding interventional coronary procedures

Mount Sinai Doctors to Present New Research at 2024 SMFM Annual Pregnancy Meeting

High-risk pregnancy specialists from the Mount Sinai Health System are presenting research at the Annual Pregnancy Meeting of the Society for Maternal-Fetal Medicine (SMFM) from February 10-14

Mount Sinai Ophthalmologists Develop Novel Protocol to Rapidly Diagnose and Treat Eye Stroke

Study shows using advanced technology and time can prevent permanent vision loss

Mount Sinai Researchers Awarded $4.1 Million NIH Grant to Advance Understanding of Sleep Apnea Using Artificial Intelligence

Machine-learning method aims to predict consequences of serious sleep disorder impacting millions in the U.S.

Posterior Wall Ablation Does Not Help Patients With Persistent Atrial Fibrillation

FOR IMMEDIATE RELEASE                  Contact:  Ilana Nikravesh                  Mount Sinai Press Office                  212-241-9200                   [email protected]   …

Largest Brain Autopsy Study of Female Intimate Partner Violence Decedents Reveals Brain Injury Pathology Unlike That Seen Among Male Contact Sports Athletes

The largest brain autopsy study of women who had experienced intimate partner violence reveals substantial vascular and white matter damage in the brain, but no evidence of chronic traumatic encephalopathy (CTE), the neurodegenerative disease recognized among male contact sports athletes who sustain repeated head trauma.

Mount Sinai Receives $4.6 Million From The Pershing Square Foundation to Support Women’s Health Research and Careers for Women in Science

The Icahn School of Medicine at Mount Sinai has received a $4.6 million gift from The Pershing Square Foundation to support women’s health research and advance careers for female scientists

Oula Announces Third Clinic And Expanded Partnership With Mount Sinai Health System To Provide Wider Access To Collaborative Maternity Care

Oula-Mount Sinai West partnership offers patients the best of obstetrics and midwifery, with midwife-led delivery supported by leading hospital’s expertise and resources

CastleVax Inc. Receives BARDA Project NextGen Award Valued at up to $338 Million to Advance Intranasal NDV-based COVID-19 Booster Vaccine into Phase 2b Clinical Efficacy Testing

CastleVax, a clinical stage vaccine platform company, has received a Project NexGen award valued at up to $338 million from the Biomedical Advanced Research and Development Authority (BARDA), to support the development of a next-generation, booster vaccine to protect against COVID-19 for years to come.

Mount Sinai Announces Partnership With the Chiba Institute of Technology in Japan Focusing on Artificial Intelligence to Transform Cardiovascular Research

Agreement aims to help make clinical trials more efficient and lead to faster advances in patient care

Mount Sinai Rehabilitation Centers Ranked Among the Best in the United States by Newsweek

Top rankings include Mount Sinai Morningside and The Mount Sinai Hospital, with stroke rehabilitation a standout program

People with Long COVID Have Distinct Hormonal and Immune Differences From Those Without This Condition

Research conducted at Mount Sinai and Yale confirms long COVID is a biological disease by showing blood biomarkers that can predict who has it

Decoding Depression: Researchers Identify Crucial Biomarker That Tracks Recovery From Treatment-Resistant Depression

A team of leading clinicians, engineers, and neuroscientists has made a groundbreaking discovery in the field of treatment-resistant depression.

Preschoolers From Low-Income Families May Have Worse Health and Benefit Less From Health Promotion Interventions Than Children With Higher Socioeconomic Status

Mount Sinai study focused on Harlem preschools emphasizes the need for specialized health promotion programs in classrooms starting at an early age

Mount Sinai Researchers Develop Novel, Automated Measure of Sleep Studies to Determine Severity of Obstructive Sleep Apnea

New method can predict risks of cardiovascular disease, mortality in sleep apnea patients

Mount Sinai Announces Partnership With the Brazilian Clinical Research Institute to Advance Cardiovascular Disease Research and Medical Education

Agreement aims to improve patient care and outcomes on a global scale

Optical Coherence Tomography May Improve Safety and Outcomes for Stenting Procedures in Heart Disease Patients Compared to Conventional Angiography

Results from a large-scale clinical trial results could increase usage of high resolution imaging for guiding interventional coronary procedures

Mount Sinai Study Identifies Most Effective and Safest Outpatient Labor Induction Methods, Potentially Reducing Hospital Stays and Increasing Hospital Efficiency in Use of Resources

Mount Sinai study identifies most effective and safest outpatient labor induction methods, potentially reducing hospital stays and increasing hospital efficiency in use of resources

Mount Sinai Receives Significant Funding to Study Which Coronary Revascularization Procedure Best Improves Survival and Quality of Life for Women and Underserved Minority Groups

The Icahn School of Medicine at Mount Sinai will help lead and launch the first clinical trial focusing on women and minority populations to determine which coronary revascularization procedure best improves their survival and quality of life.

Promising Results of Next-Generation Intranasal COVID-19 Booster Vaccine: Implications for Infection Prevention and Transmission

The Icahn School of Medicine at Mount Sinai in New York, NY is pleased to announce that CastleVax, Inc. has completed enrollment and a preliminary analysis of a phase 1 trial of its licensed Newcastle disease virus (NDV)-based COVID-19 booster vaccine.

Mount Sinai Participates in $40 Million Multisite Study of Alzheimer’s Disease in Asian Americans and Asian Canadians

Study represents a major milestone toward health equity for underrepresented populations in Alzheimer’s disease research

Mount Sinai Launches Center for Ophthalmic Artificial Intelligence and Human Health

The Icahn School of Medicine at Mount Sinai has launched the Center for Ophthalmic Artificial Intelligence and Human Health, the first of its kind in New York and one of the first in the United States.

Mount Sinai Patients Receive Greater and Faster Access to Care With New Expanded Digital Tools

Mount Sinai Health System patients will experience greater access to care, fast identification of symptoms, efficient online search and connection to specialists, and easy appointment scheduling thanks to newly launched Digital Experience tools accessible on their smartphones or computers.

Patients With Specific Types of Lipids May Be at Higher Risk of Developing Blinding Eye Disease

Principal Investigator: Louis R. Pasquale, MD, FARVO, Deputy Chair for Ophthalmology Research for the Mount Sinai Health System Co-First Authors: Oana A. Zeleznik, PhD, Instructor in Medicine at Brigham and Women’s Hospital and Jae H. Kang, ScD, Assistant Professor of…

Mount Sinai Experts Present Research at SLEEP 2023

Sleep medicine experts from the Mount Sinai Health System are presenting new research at SLEEP 2023, the 37th annual meeting of the Associated Professional Sleep Societies running until June 7 in Indianapolis.

Researchers Show That a Machine Learning Model Can Improve Mortality Risk Prediction for Cardiac Surgery Patients

A machine learning-based model that enables medical institutions to predict the mortality risk for individual cardiac surgery patients has been developed by a Mount Sinai research team, providing a significant performance advantage over current population-derived models.

Coronary Bioresorbable Scaffolds Nearly as Safe and Effective as Conventional Metal Stents for Heart Disease Patients

First-generation bioresorbable vascular scaffolds (BVS) may be just as effective as drug-eluting metallic stents, which are currently the standard treatment for heart disease patients undergoing percutaneous coronary intervention (PCI).

Mount Sinai Launches Institute for Regenerative Medicine

Institute, including three new centers, will lead research to foster novel discoveries and explore new treatments for a range of diseases from leukemia to Alzheimer’s disease.

Mount Sinai Awarded Prestigious $1.3 Million Grant to Expand Research Training Program in Skin Biology

The Kimberly and Eric J. Waldman Department of Dermatology at the Icahn School of Medicine at Mount Sinai will expand its research training program in skin biology with support from a five-year, $1.3 million T32 grant from the National Institutes of Health (NIH) and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS).

NYC Mayor Eric Adams Joined Top Biomedical Researchers to Usher in the Center for Engineering and Precision Medicine at Hudson Research Center at 619 West 54th Street

The grand opening of the Center for Engineering and Precision Medicine (CEPM), a partnership between Rensselaer Polytechnic Institute (RPI) and the Icahn School of Medicine at Mount Sinai (Icahn Mount Sinai), was held March 29, 2023 at the Hudson Research Center (HRC) at 619 West 54th Street. The center is the latest in a 10+ year partnership between RPI, a world-renowned technological research university known for its engineering, technology, and science programs, and Icahn Mount Sinai, the academic arm of the Mount Sinai Health System, which includes eight hospitals and a vast network of ambulatory practices throughout the greater New York City region.